NCT07059013

Brief Summary

Autism spectrum disorder (ASD) is characterized by varying degrees of disability and deviation in social communication, cognitive growth, and emotional expression, as well as the existence of constrained, repetitive patterns of behavior and interests and sensory processing issues. Caring for children with ASD can be a stressful and challenging life event for parents, potentially leading to a higher risk of mental health issues and other negative outcomes. Poor mental health in these parents can be attributed to various factors, such as the perception of having little control over their child's behavior, concerns about the child's intellectual development and ability to acquire adaptive behaviors, the demands of caregiving and time management, worries about parent-child relationships, and uncertainty about the child's future. The mental well-being of parents of children with ASD is essential in both clinical and research settings, as it can impact potential treatment results. Research has demonstrated that stress experienced by these parents can be linked to reduced participation in services and less favorable behavioral and developmental outcomes for their children in early intervention programs. The success of interventions mediated or delivered by parents is closely tied to their mental well-being, which affects both their involvement in treatments and adherence to them. Therefore, it is vital to focus on enhancing the mental health of parents when designing intervention children with ASD and their families. Emerging evidence supports the use of Positive Psychotherapy (PPT). PPT was originally proposed by Seligman and colleagues and consists a series of evidenced-based positive psychological skills exercises aimed at fostering positive emotions, cognition, characteristics, and behaviors. PPT focuses on individuals' strengths and resources, distinguishing it from traditional psychotherapies. PPT is brief, requiring only a few sessions, Its instructions are straightforward and easy-to-follow, allowing for self-adminstration. Research has shown that PPT not only reduces depressive symptoms, stress and anxiety, but also places equal emphasis on enhancing well-being in individuals with major depression. Taken together, the investigators hypothesize that PPT can improve well-being, reduce stress, depressive symptoms, and enhance the quality of life in Chinese parents of children with ASD. Digital health interventions, particularly Chatbots, have the potential to expand the reach and impact of positive psychology skills interventions for parents of children with ASD. There are several advantages to using Chatbots. First, Chatbots are perceived as accessible and can provide a structured set of content that simulates real-life conversations with a supportive friend. This is particularly important for parents of children with ASD who may lack social support. Second, access to the effective psychological interventions can be limited due to geographical barriers, lack of resources, or social stigma. Digital interventions, such as Chatbots, can help overcome these barriers by providing easy access to evidence-based psychological interventions. Chatbots can be available 24/7, can be personalized to individual needs, and can offer immediate feedback and support. Third, Chatbots can collect data on users' interactions, which can inform the improvement and adaptation of the intervention. The use of Chatbots to promote health conversations is an emerging field. A review of 12 studies suggested that no adverse events or harms were reported but there was a lack of studies assessing mental health outcomes. Hence, in this proposed study, the investigators will develop and test the first Chatbot to improve well-being in caregivers of children with ASD. Aims: The objective is to evaluate and test the Chatbot-based program in promoting well-being in caregivers of children with ASD. The secondary objectives are: To test if the Chatbot-based program reduces perceived stress in caregivers of children with ASD; To test if the Chatbot-based program reduces depressive symptoms in caregivers of children with ASD; To test if the Chatbot-based program improves quality of life in caregivers of children with ASD; To test if the Chatbot-based program is feasible of children with ASD. Methods: The randomised controlled trial with a mixed-method evaluation will be designed. A total of 130 caregivers of children with ASD will be randomly allocated into the control or intervention group. Participants will be randomly allocated to the Chatbot-based program and receive one-page information about ASD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

April 30, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

April 30, 2025

Last Update Submit

December 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Well-being

    Measured by the World Health Organization-5 Wellbeing Index (WHO-5) to evaluate vitality (being active and waking up fresh and rested), being interested in things, and having a pleasant attitude. Each item is scored using a 6-point Likert scale from at no time (0) to all of the time (5). The total score ranges from 0 to 25, with higher scores suggesting better self-perceived well-being.

    Baseline, 3-month follow-up and 6-month follow-up

Secondary Outcomes (4)

  • Depressive symptoms

    Baseline, 3-month follow-up and 6-month follow-up

  • Quality of life (QoL)

    Baseline, 3-month follow-up and 6-month follow-up

  • Chatbot Feasibility (Quantitative outcome)

    3-month follow-up, 6-month follow-up

  • Parenting stress index

    Baseline, 3-month follow-up and 6-month follow-up

Other Outcomes (2)

  • Adverse events

    through study completion, an average of 1 year

  • Chatbot feasibility (qualitative outcome)

    6-month follow-up

Study Arms (2)

Chatbot group

EXPERIMENTAL

The participants will be asked to communicate with the Chatbot.

Device: Chatbot

Control group

NO INTERVENTION

One-page health information about ASD will be provided to the participants

Interventions

ChatbotDEVICE

The Chatbot will be designed using open-source conversational AI, such as GPT. The Chatbot will include three modules: individual strength, information, and Peer Networks. 1. Individual Strength Include eight positive psychology exercises: positive introduction, personal strengths, using strengths, three good things, gratitude letter/visit, hope and optimism, active/constructive responding, and savoring. 2. Information Include available healthcare services, parenting skills for children with ASD, the health information for ASD, the financial assistance provided by public and private funding, educational resources, and community resources. 3. Peer Networks Participants can share their experiences about adapting after their child's diagnosis and read others' sharing.

Chatbot group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • caregivers providing long-term care for the children with a diagnosis of ASD from a qualified clinician, confirmed through the provision of documentation by the parents;
  • caregivers of primary-school-age child (6-11 years old) (this age range is selected because social and communication interaction of children with ASD may be progressively more awkward in this age range when the social demands become more prominent);
  • caregivers who are over 18 years old;
  • caregivers who have the ability to communicate and read in Chinese;

You may not qualify if:

  • Unwilling to complete the questionnaires at 3 time points;
  • Diagnosis of severe psychiatric disorder (such as schizophrenia and severe bipolar disorder) or cognitive impairment;
  • Participation of a similar psychological intervention within one year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hong Kong Metropolitan University

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 30, 2025

First Posted

July 10, 2025

Study Start

August 15, 2025

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

December 17, 2025

Record last verified: 2025-12

Locations